FDA Inspection
Rex Garn Mabey Jr., M.D.Rex Garn Mabey Jr., M.D. – FDA Inspection, Oct 19, 2012
Record Details
This FDA Inspection record concerns Rex Garn Mabey Jr., M.D., with an inspection on October 19, 2012, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Rex Garn Mabey Jr., M.D.
- Inspection Date
- October 19, 2012
- Product Type
- Drugs
View Company Profile
ID · 49d4ab14-ef35-45bd-b8bf-38cbe66bb391
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 806882
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
FDA Citations
2- 21 CFR 312.60FD-1572, protocol compliance
- 21 CFR 312.60Informed consent
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Rex Garn Mabey Jr., M.D.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| November 5, 2024 | NAI | San Francisco District Office | Bioresearch Monitoring: Human Drugs |
| November 29, 2021 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| October 20, 2017 | Not classified | San Francisco District Office | |
| June 9, 2017 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| June 9, 2009 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Rex Garn Mabey Jr., M.D.
- FDA Inspection 1253858 - 2024-11-05
- FDA Inspection 1157839 - 2021-11-29
- FDA Inspection 1033969 - 2017-10-20
- FDA Inspection 1017040 - 2017-06-09
- FDA Inspection 579688 - 2009-06-09
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.